#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Colorectal cancer metastatic Obesity Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Carcinoid syndrome Cerebral arteriovenous malformation haemorrhagic Adrenocortical carcinoma Hypochondroplasia Malignant melanoma Dementia with Lewy bodies Krabbe's disease Central nervous system neoplasm Porphyria non-acute Adrenoleukodystrophy Arteriovenous malformation Pyruvate dehydrogenase complex deficiency Juvenile chronic myelomonocytic leukaemia Cutaneous T-cell lymphoma stage II Glycogen storage disease type I More trials…

    Learn about Rare Diseases

    Mucopolysaccharidosis Fabry’s disease – Treatment Mucous membrane pemphigoid – Trials in Disease Sarcoidosis – Life with Disease Lymphangioma – Life with Disease Mantle cell lymphoma stage IV – Diagnostics Wiskott-Aldrich syndrome – Diagnostics Phenylketonuria Ewing’s sarcoma recurrent – Trials in Disease VEXAS syndrome – Treatment More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Anhydrous Caffeine Ly3537982 Alternaria Alternata Extract GSKVX000000070250 Orismilast Corylus Avellana L. Golodirsen ZINC Dorzolamide Hydrochloride Naproxen Sodium LTX-002 SODIUM Mexiletine Hydrochloride Tecovirimat Follitropin Alfa Obeticholic Acid Haloperidol Pariglasgene Brecaparvovec Valine Isosorbide Dinitrate Nimorazole More therapies…

    Learn about Your Condition

    Craniocerebral injury Tetanus Obsessive-compulsive disorder Connective tissue disorder Small cell carcinoma Head and neck cancer stage IV Thyroid cancer metastatic Graves' disease Pulmonary sarcoidosis Thrombocytosis Hand dermatitis HIV infection Albuminuria Hepatoblastoma Measles More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

ABM

  • Study of XELOX chemotherapy with or without dostarlimab after chemoradiation in patients with locally advanced rectal cancer

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Rectal cancer
    Investigated Drugs:
    • Dostarlimab
    Italy

  • Study of Izalontamab Brengitecan Compared to Standard Chemotherapy in Untreated Triple-negative or ER-low, HER2-negative Breast Cancer Patients Not Eligible for Anti-PD1/PD-L1 Treatment

    Recruiting

    4 1 1 1
    Investigated Drugs:
    • Gemcitabine
    • Capecitabine
    • Paclitaxel Albumin-Bound
    Austria France Germany Greece Italy Poland +4

  • Study of IMVT-1402 in Adults with Mild to Severe Generalized Myasthenia Gravis

    Recruiting

    3 1
    Investigated Diseases:
    • Myasthenia gravis
    Investigated Drugs:
    • IMEROPRUBART
    Czechia Denmark Germany Greece Hungary Italy +3

  • Comparison of Pregabalin and Baclofen Treatment in Patients with Spastic Motor Behavior Following Cervical or Thoracic Spinal Cord Injury

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Muscle spasticity
    Investigated Drugs:
    • Baclofen
    • Pregabalin
    Czechia

  • Study of Trastuzumab Deruxtecan Blood Levels in Normal Weight and Overweight Patients with Metastatic Breast Cancer

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Breast cancer metastatic
    Investigated Drugs:
    • Trastuzumab Deruxtecan
    France

  • Study of inhaled corticosteroids (beclometasone, fluticasone, budesonide) and salbutamol in children aged 1-6 years with episodic wheezing

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Wheezing
    Investigated Drugs:
    • Beclometasone Dipropionate
    • Fluticasone Propionate
    • Salbutamol Sulfate
    The Netherlands
Previous Page
1 … 122 123 124 125 126 … 1,648
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!